跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack - TGA Drug Approval Details
Approvals
/
TGA
/
TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
Approved
STANDARD
TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
c8e81a54e2cfdf68
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c8e81a54e2cfdf68
Product Name
TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
Artg Id
475545
Artg Name
TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2025-03-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
c8e81a54e2cfdf68
Type
Standard
Back to TGA Approvals
